Navigation Links
DelMar Pharma Named to Rocket Builders' 2013"Ready to Rocket" List
Date:3/13/2013

VANCOUVER, British Columbia and MENLO PARK, Calif., March 13, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar") today announced that the Company has been named to Rocket Builder's 11th annual "Ready to Rocket" list.

Rocket Builders "Ready to Rocket" list recognizes British Columbia technology companies that are best positioned to capitalize on the 2012 technology sector trends that will lead them to faster growth than their peers. According to Rocket Builders, the annual "Ready to Rocket" lists provide accurate predictions of companies that will likely experience significant growth, venture capital investment or acquisition by a major player in the coming year.

"Each year, our team of analysts received lots of inquiries on how we are able to predict so accurately which companies will grow revenue," said Geoffrey Hansen , Managing Partner at Rocket Builders. "Three elements characterize these high growth firms: a growing market opportunity, a unique competitive position and customer validation of a must-have value proposition."

"As a new public company, we are pleased to receive this important recognition of our recent accomplishments as we seek to implement our strategy to develop break-through cancer medicines for orphan cancer indications," stated Jeffrey Bacha , President & CEO of DelMar Pharma.

The 2013 list features 10 companies, and the list can be found here: http://www.readytorocket.com/2013/03/2013-ready-to-rocket-life-science-list.html.

According to Thealzel Lee, Senior Partner at Rocket Builders, "We are pleased to include DelMar Pharma in our Ready to Rocket list for 2013. DelMar's recent corporate accomplishments position the company for leadership in the '/>"/>

SOURCE DelMar Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. DelMar Pharmaceuticals to Present Interim Clinical Data on VAL-083 in Refractory Glioblastoma at Society for Neuro-Oncology (SNO) Annual Meeting
2. DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement
3. DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement
4. DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors
5. DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant
6. DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference
7. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
8. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
9. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
10. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
11. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of their GLPG0634 ... fund and complete a Phase 2 program in Crohn,s ... Phase 3.  Upon successful completion of the study, expected ... The terms of the collaboration extension are in addition ...
(Date:5/16/2013)... May 16, 2013  Nektar Therapeutics, (Nasdaq: NKTR ... Robin , is scheduled to present at the upcoming ... at the Sheraton New York Hotel on Tuesday, ... The presentation will be accessible via a Webcast through a ... the Nektar website: http://www.nektar.com . This Webcast will be ...
(Date:5/16/2013)... and SYDNEY , May 16, 2013 /PRNewswire/ ... HIN), a leading innovator of less invasive, miniaturized circulatory support ... today announced that CEO Doug Godshall ... Conference at 11:00 a.m. EDT on Monday, May 20, 2013.  ... Sheraton New York Hotel. A live webcast of ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6Nektar Therapeutics' President and CEO, Howard W. Robin, To Present at the 2013 UBS Global Healthcare Conference in New York City 2HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2
(Date:5/19/2013)... Springs, FL (PRWEB) May 19, 2013 Omaha, ... It is also a city with one of the lowest ... ranking it eleventh in their Best Places for Business and ... for Relocation lists. Omaha is centrally located in the ... stalwarts of industry located there. The producers of Editions ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Actos ... federal litigation now underway in U.S. District Court, Western ... Order dated May 3rd, the Court has modified the ... to eight cases rather than four. The next Status ... Thursday, May 23rd. (In re: Actos Product Liability Litigation, ...
(Date:5/19/2013)... California (PRWEB) May 19, 2013 Grinding ... than just losing sleep, or annoying your spouse. At ... report by CNY Central (“Snoring and Teeth Grinding Could ... type of teeth grinding can be hard to prevent. ... million Americans, and one of its symptoms is a ...
(Date:5/19/2013)... 19, 2013 These molecular diagnostics ... UK, Spain, Japan, Italy, Germany and France:, ... diagnostics laboratory practice, as well as key economic, ... market impact during the next five years. , ... biochip technologies, test formats, detection methodologies, trends in ...
(Date:5/19/2013)... York, New York (PRWEB) May 19, 2013 ... that a Case Management Conference was recently convened for ... a federal multidistrict litigation now underway in U.S. District ... posted on the Court’s website on May 14th, the ... It was also reported during the Conference that ...
Breaking Medicine News(10 mins):Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3
... have lower risks of Alzheimer,s disease and other cognitive ... In more than half of the studies, published since ... had lower dementia risks than nondrinkers. In only a ... a two-edged sword," said Michael Collins, Ph.D., a professor ...
... Review Examines All Aspects of Hospital OperationsCAMBRIDGE, Mass., ... survey of Cambridge Health Alliance by The Joint ... safety and quality of health care in the ... CHA,s chief executive officer, and "is the best ...
... bid to force TomoTherapy to consider strategic alternativesMADISON, Wis., Dec. ... Capital Group, announced that on December 23, 2008 it nominated ... Inc. (Nasdaq: TOMO ). This step is the ... for the company,s shareholders in the wake of the precipitous ...
... Mich., Dec. 29 Versus Technology,Inc. ("Versus" or ... year ended Oct. 31, 2008, compared to revenues ... the fiscal quarter ended Oct. 31, 2008, were,$1,748,000 ... period in 2007.,Versus, quarterly revenues can vary significantly ...
... Hebrew University of Jerusalem have succeeded in reversing brain birth ... brain cells. , The work of Prof. Joseph Yanai ... presented at the Tel Aviv Stem Cells Conference last spring ... at the seventh annual meeting of the International Society ...
... 29 After retiring from a night-shift job 12 years ... on TV shows, including Monday Night Football. He also ate ... caught up with him: He became overweight and was diagnosed ... when he knew he had to change his lifestyle."It was ...
Cached Medicine News:Health News:Moderate drinking can reduce risks of Alzheimer's dementia and cognitive decline 2Health News:Joint Commission Reports Positive Survey Results for CHA 2Health News:Joint Commission Reports Positive Survey Results for CHA 3Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 2Health News:Avalon Portfolio Nominates Slate of Directors for TomoTherapy Board 3Health News:Versus Technology Announces Fiscal Year Results 2Health News:Versus Technology Announces Fiscal Year Results 3Health News:Versus Technology Announces Fiscal Year Results 4Health News:Versus Technology Announces Fiscal Year Results 5Health News:Versus Technology Announces Fiscal Year Results 6Health News:Versus Technology Announces Fiscal Year Results 7Health News:Hebrew University scientists succeed through stem cell therapy in reversing brain birth defects 2Health News:African Americans to Reach Health Resolutions Through Search Your Heart 2
Fine pointed grooved jaws with smooth curve from tip to finger grip style handle. Dull finish....
Inner jaw space 2.0 mm - 45 degree tip angulation. 20 gauge (.89 mm) diameter shaft and stationary distal jaw. Lightweight squeeze handle with dull finish. Jaws 1.5 mm serrated....
Straight shafts with 5.5 mm tying platform and 45 degree 0.3 mm teeth. Wide serrated handle with polished finish....
Straight shafts with 1 x 2 teeth. Flat handle with polished finish....
Medicine Products: